Välkommen till Medivir
Open/Close

13 May 14:30

Bo Öberg and Nils-Gunnar Johansson have sold B-class shares

24 Apr 12:26

New Phase IIa data on TMC435 in patients with hepatitis C presented at the ongoing EASL - meeting

more news »


Senaste rapporter
MEDIVIR, INTERIM REPORT, 1 JANUARY – 31 MARCH 2009
ANNUAL REPORT 2008

Forthcoming reports 2009
The Six-month Interim Report will be published on 9 July
The Nine-month Interim Report will be published on 21 October

Focus on heptit C

Strong phase IIa data for TMC435 were recently presented at the EASL conference. These data support further development of TMC435 in both naive and treatment experienced HCV patients. Phase IIb trials in naïve patients will start before summer followed by phase IIb trials in treatment experienced HCV patients.

Several significant corporate and
project events were reported in
the quarter.
Read CEO comment »